← SynDRA
TENALISIB
SynDRA canonical compound SYN0039683 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PIK3CD | PIK3CG |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- PIK3CG INHIBITOR
- PI3-kinase p110-gamma subunit inhibitor
- PI3K inhibitor
Drug classes
- Phosphoinositide-3 Kinase Inhibitors
Cross-references
Synonyms
- Rp-6530
- RP6530
- HDXDQPRPFRKGKZ-INIZCTEOSA-N
- UNII-2261HH611H
- 2261HH611H
- Tenalisib [INN]
- GTPL9907
- SCHEMBL16279460
- AKOS027325582
- RP 6530
- CS-6375
- HY-17645
- 4H-1-Benzopyran-4-one, 3-(3-fluorophenyl)-2-((1S)-1-(9H-purin-6-ylamino)propyl)-
- (S)-2-(1-((7H-purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one
- 3-(3-fluorophenyl)-2-[(1S)-1-[(9H-purin-6-yl)amino]propyl]-4H-chromen-4-one
- 3-(3-Fluorophenyl)-2-((1S)-1-((7H-purin-6-yl)amino)propyl)-4H-1-benzopyran-4-one
- tenalisibum
- RefChem:187826
- Tenalisib (RP6530)
- C23H18FN5O2
- RP6530, Tenalisib
- TENALISIB [WHO-DD]
- orb1309019
- SCHEMBL21828463
- SCHEMBL29369874
- SCHEMBL29370345
- SCHEMBL29506722
- SCHEMBL29921996
- SCHEMBL30157094
- SCHEMBL30257227
- EX-A2699
- PQC41753
- BDBM50512870
- MFCD28502205
- NSC803014
- s8672
- AKOS037645008
- CCG-268828
Look up TENALISIB in the interactive SynDRA portal →